XIPERE (nda211950)- (40MG/ML)

Generic Name	TRIAMCINOLONE ACETONIDE	Innovator	BAUSCH AND LOMB INC
Dosage	40MG/ML
ParaIV Filing	No	505(b)2 Filing	No
Last Patent Expiry	2034-May-02	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	2024-Oct-22
GAIN Expiry	None	Drug Complexity	No
Indication	XIPERE™ is a corticosteroid indicated for the treatment of macular edema associated with uveitis.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
40MG/ML	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
Yes	0

Manufacturing Details of XIPERE